Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP803719.RAgcPRv8SzqfukdhNSzhpD1Q_zSoVg6CSxwk0itrQwSvU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP803719.RAgcPRv8SzqfukdhNSzhpD1Q_zSoVg6CSxwk0itrQwSvU130_assertion type Assertion NP803719.RAgcPRv8SzqfukdhNSzhpD1Q_zSoVg6CSxwk0itrQwSvU130_head.
- NP803719.RAgcPRv8SzqfukdhNSzhpD1Q_zSoVg6CSxwk0itrQwSvU130_assertion description "[Activating extrinsic apoptotic pathways targeting death receptors (DR) using agonistic antibodies or TNF-related apoptosis-inducing ligand (TRAIL) is promising for cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP803719.RAgcPRv8SzqfukdhNSzhpD1Q_zSoVg6CSxwk0itrQwSvU130_provenance.
- NP803719.RAgcPRv8SzqfukdhNSzhpD1Q_zSoVg6CSxwk0itrQwSvU130_assertion evidence source_evidence_literature NP803719.RAgcPRv8SzqfukdhNSzhpD1Q_zSoVg6CSxwk0itrQwSvU130_provenance.
- NP803719.RAgcPRv8SzqfukdhNSzhpD1Q_zSoVg6CSxwk0itrQwSvU130_assertion SIO_000772 23833311 NP803719.RAgcPRv8SzqfukdhNSzhpD1Q_zSoVg6CSxwk0itrQwSvU130_provenance.
- NP803719.RAgcPRv8SzqfukdhNSzhpD1Q_zSoVg6CSxwk0itrQwSvU130_assertion wasDerivedFrom befree-20150227 NP803719.RAgcPRv8SzqfukdhNSzhpD1Q_zSoVg6CSxwk0itrQwSvU130_provenance.
- NP803719.RAgcPRv8SzqfukdhNSzhpD1Q_zSoVg6CSxwk0itrQwSvU130_assertion wasGeneratedBy ECO_0000203 NP803719.RAgcPRv8SzqfukdhNSzhpD1Q_zSoVg6CSxwk0itrQwSvU130_provenance.